Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay

Sequencing of cell-free DNA (cfDNA) in cancer patients’ plasma offers a minimally-invasive solution to detect tumor cell genomic alterations to aid real-time clinical decision-making. The reliability of copy number detection decreases at lower cfDNA tumor fractions, limiting utility at earlier stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlando, Francesco, Romanel, Alessandro, Trujillo, Blanca, Sigouros, Michael, Wetterskog, Daniel, Quaini, Orsetta, Leone, Gianmarco, Xiang, Jenny Z, Wingate, Anna, Tagawa, Scott, Jayaram, Anuradha, Linch, Mark, Jamal-Hanjani, Mariam, Swanton, Charles, Rubin, Mark A, Wyatt, Alexander W, Beltran, Himisha, Attard, Gerhardt, Demichelis, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154344/
https://www.ncbi.nlm.nih.gov/pubmed/35664542
http://dx.doi.org/10.1093/narcan/zcac016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154344/
https://www.ncbi.nlm.nih.gov/pubmed/35664542
http://dx.doi.org/10.1093/narcan/zcac016

Ejemplares similares